In an extensive analysis of various B and T-cell lymphomas to validate MEF-2B as an immunohistochemical marker, the expression revealed a statistically significant association with BCL6 in DLBCL and indicates MEF-2B as a valuable marker for differential diagnosis of various types of lymphomas [193]. Here, MEF2B is linked to lymphoma.